Tadashi Yamamuro

Independent Laboratory Head

National Cerebral and Cardiovascular Center
Country flagJapan

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (8)

Year:

2026

Year:

2026

Year:

2025

Mitochondria provide a variety of metabolites, in addition to ATP, to meet cell-specific needs. One such metabolite is phosphoenolpyruvate (PEP), which contains the highest energy phosphate bond above ATP, and has diverse biological functions, including glycolysis, gluconeogenesis, and glyceroneogenesis. Although PEP is generally considered a cytosolic intermediate, it can also be synthesized within mitochondria by the mitochondria-localized carboxykinase (PCK2, also known as M-PEPCK). However, the mechanism by which mitochondrial PEP is delivered to the cytosolic compartment and caters to cell-specific requirements remains elusive. Here, we identify SLC25A35, a previously uncharacterized mitochondrial inner-membrane protein, as the long-sought carrier responsible for mitochondrial PEP efflux. SLC25A35 is highly expressed in lipogenic cells, such as adipocytes, which employ the mitochondrial pyruvate-to-PEP bypass, and is upregulated by lipogenic stimuli. Reconstitution studies by proteo-liposomes, together with structural analyses, demonstrated specific PEP transport by SLC25A35 in a pH gradient-dependent manner. Importantly, loss of SLC25A35 in adipocytes impaired the conversion of mitochondrial PEP into glycerol-3-phosphate, the glycerol backbone in triglyceride, resulting in reduced glycerolipid synthesis while preserving substrate oxidation in the TCA cycle. Furthermore, blockade of SLC25A35 in the liver of obese mice markedly decreased glycerolipid accumulation, ameliorated hepatic steatosis, and improved systemic glucose homeostasis. Together, the present study identifies mitochondrial PEP transport via SLC25A35 as a metabolic checkpoint of fatty acid esterification, offering a selective target for “lipogenic mitochondria” to limit glycerolipid synthesis, a pivotal step in the pathogenesis of hepatic steatosis and Type 2 diabetes.

Year:

2025

Year:

2024

Year:

2024

Recent evidence suggests an association between age‐related osteoporosis and cellular senescence in the bone; however, the specific bone cells that play a critical role in age‐related osteoporosis and the mechanism remain unknown. Results revealed that age‐related osteoporosis is characterized by the loss of osteoblast Men1 . Osteoblast‐specific inducible knockout of Men1 caused structural changes in the mice bones, matching the phenotypes in patients with age‐related osteoporosis. Histomorphometrically, Men1 ‐knockout mice femurs decreased osteoblastic activity and increased osteoclastic activity, hallmarks of age‐related osteoporosis. Loss of Men1 induces cellular senescence via mTORC1 activation and AMPK suppression, rescued by metformin treatment. In bone morphogenetic protein‐indued bone model, loss of Men1 leads to accumulation of senescent cells and osteoporotic bone formation, which are ameliorated by metformin. Our results indicate that cellular senescence in osteoblasts plays a critical role in age‐related osteoporosis and that osteoblast‐specific inducible Men1 ‐knockout mice offer a promising model for developing therapeutics for age‐related osteoporosis.

Year:

2024

Year:

2024

Collaborators (13)

Maho Hamasaki

Osaka University

JAPAN
View details

Takeshi Imamura

Professor

Ehime University

JAPAN
View details

Kazuaki Maruyama

Assistant Professor

Mie University Graduate School of Medicine

JAPAN
View details

Akiko Kuma

Specially Appointed Associate Professor

Osaka University

JAPAN
View details

Jun Matsuda

McGill University Health Centre

CANADA
View details

Lijun Sun

Associate Professor

Beth Israel Deaconess Medical Center

UNITED STATES
View details

Mark Li

Harvard University

UNITED STATES
View details

Jihoon Shin

Assistant Professor

Beth Israel Deaconess Medical Center, Harvard Medical School

UNITED STATES
View details

Shunbun Kita

Associate Professor

Osaka University

JAPAN
View details

Shingo Kajimura

Principal Investigator

Harvard Medical School

UNITED STATES
View details

Satoshi Minami

特任助教(常勤)

Osaka University

JAPAN
View details

Guilherme Martins Silva

Researcher Specialist

Brazilian Center for Research in Energy and Materials

BRAZIL
View details

Tatsuya Kaminishi

Specially Appointed Assistant Professor

Osaka University

JAPAN
View details